Versant Capital Management’s Avita Medical RCEL Stock Holding History

Versant Capital Management’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-441	Closed	-$1.63K	–	2835
2026 Q1	$1.63K	Buy	+441	New	+$1.85K	﹤0.01%	2594
2025 Q2	–	Sell	-576	Closed	-$4.69K	–	2718
2025 Q1	$4.69K	Buy	576 +17	+3%	+$159	﹤0.01%	2048
2024 Q4	$7.16K	Buy	+559	New	+$6.59K	﹤0.01%	1572

Other funds holding RCEL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SIC

SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

WETS

Wealth Enhancement Trust Services Sioux Falls, South Dakota $900M AUM

Versant Capital Management's RCEL Position: Q2 2026 in Review

Versant Capital Management sold out of Avita Medical (RCEL) in Q2 2026, closing a stake of 441 shares — an estimated $1.63K sold.

Versant Capital Management first reported a position in RCEL in Q4 2024 and held it in 3 quarters. The position peaked at $7.16K in Q4 2024. 7 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

Versant Capital Management reported no remaining Avita Medical position as of Q2 2026 after selling out during the quarter.
Versant Capital Management sold 441 Avita Medical shares in Q2 2026, an estimated $1.63K.
Versant Capital Management first reported a position in Avita Medical in Q4 2024 and held it in 3 quarters.
Versant Capital Management's Avita Medical position peaked at $7.16K in Q4 2024.
7 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.